Novel Topical Drug Delivery Systems in Ophthalmic Applications

Abstract

The eye is the utmost attention-grabbing organ owed to its drug disposition characteristics. Generally, topical application (90% are eye drops) is the method of choice because of its patient compliance and safety. Transcorneal penetration is the major route for ophthalmic drug absorption. However, corneal absorption has been observed to be slower process as compared to elimination. Therefore, conventional dosage forms are associated with rapid precorneal drug loss. Thus, to improve ocular drug bioavailability, there is a substantial effort directed toward the development of novel topical drug delivery systems for ophthalmic administration. These novel delivery systems (Contact lenses, In situ gels, Microemulsions, Niosomes, Liposomes, Implants, Microspheres, and Micelles) provide the controlled release behaviour for treating the chronic ailments, and help patients and doctors to curtail the dosing frequency and invasive method of treatment. Hence, the current chapter discusses the progress of novel topical ocular drug delivery systems in the pharmaceutical industry.